MKC
54
3
ZTS
38
4
ADP
57
2
DE
49
3
SLG
37
6
KEY
24
2
FCX
44
4
FOX
71
3
CMI
49
2
PSX
24
2
ESS
44
5
PH
60
5
TROW
37
8
BAX
38
2
V
70
14
TGNA
48
5
EMC
30
-26
KR
50
5
EXPD
29
2
AAL
56
5
MKC
54
3
ZTS
38
4
ADP
57
2
DE
49
3
SLG
37
6
KEY
24
2
FCX
44
4
FOX
71
3
CMI
49
2
PSX
24
2
ESS
44
5
PH
60
5
TROW
37
8
BAX
38
2
V
70
14
TGNA
48
5
EMC
30
-26
KR
50
5
EXPD
29
2
AAL
56
5
Financhill
Back

Monte Rosa Therapeutics Vs. Novo Nordisk AS Industry Stock Comparison

Sell
21

GLUE
Monte Rosa Therapeutics

Last Price:
$6.92
Seasonality Move:
-3.94%
Sell
23

NVO
Novo Nordisk AS

Last Price:
$85.00
Seasonality Move:
6.92%
Sell
21
Monte Rosa Therapeutics (GLUE) is a Sell

Is Monte Rosa Therapeutics a Buy, Sell or Hold?

  • The current Monte Rosa Therapeutics [GLUE] share price is $6.91. The Score for GLUE is 21, which is 58% below its historic median score of 50, and infers higher risk than normal.
  • GLUE is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
23
Novo Nordisk AS (NVO) is a Sell

Is Novo Nordisk AS a Buy, Sell or Hold?

  • The current Novo Nordisk AS [NVO] share price is $85.00. The Score for NVO is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • NVO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

GLUE Stock Price Chart

What is Monte Rosa Therapeutics's stock price today?

  • The Monte Rosa Therapeutics share price today is $6.91
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GLUE is experiencing slight buying pressure.

NVO Stock Price Chart

What is Novo Nordisk AS's stock price today?

  • The Novo Nordisk AS share price today is $85.00
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVO is experiencing slight buying pressure.

GLUE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.34 Sell
Relative Strength Index (14 RSI): 39.42 Sell
Chaikin Money Flow: 968460 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (7.45 - 9.53) Sell
Bollinger Bands (100): (4.82 - 8.52) Buy

NVO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.5 Sell
Relative Strength Index (14 RSI): 19.69 Sell
Chaikin Money Flow: 20899665 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (100.63 - 110.99) Sell
Bollinger Bands (100): (107.27 - 131.41) Sell

GLUE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 7.46 Sell
20-day SMA: 8.59 Sell
50-day SMA: 7.94 Sell
200-day SMA: 5.93 Buy
8-day EMA: 7.49 Sell
20-day EMA: 8.11 Sell
50-day EMA: 7.84 Sell
200-day EMA: 6.37 Buy

NVO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 104.71 Sell
20-day SMA: 106.65 Sell
50-day SMA: 109.28 Sell
200-day SMA: 126.25 Sell
8-day EMA: 102.07 Sell
20-day EMA: 105.53 Sell
50-day EMA: 110.02 Sell
200-day EMA: 118.09 Sell

Monte Rosa Therapeutics Earnings Growth & GLUE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.44 per share, and a decrease next year of $0.60 per share.

Novo Nordisk AS Earnings Growth & NVO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.49 per share, and an increase next year of $0.72 per share.

Monte Rosa Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Novo Nordisk AS Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):